経口5-ASAによる潰瘍性大腸炎の治療に関する観察研究

基本情報

NCT ID

NCT01654783

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

5,704

治験依頼者名

Kyorin Pharmaceutical Co.,Ltd

概要

The objectives of this study are to investigate how oral 5-ASA drugs have been used in the condition without symptoms such as abdominal pain or diarrhea/bloody stool (remission stage), or in the transition from the condition with symptoms such as abdominal pain or diarrhea/bloody stool (active stage) to the remission stage in ulcerative colitis and to study how many patients will be able to maintain the remission stage during the observation period and how many times the patients will experience the active stage (relapse), as well as how symptoms will change during the observation period to discover better treatment plans.

対象疾患

依頼者（Sponsor）

実施施設 (1)